Innogenetics sues Abbott and Third Wave

Belgian pharmaceutical group Innogenetics said it has filed complaints in the US against Abbott Laboratories and the US' Third Wave Technologies for patent infringement of one of its hepatitis C (HCV) virus genotyping patents, and that the proceedings may impact its revenues for this year and 2006. [from AFX through Forbes]

See earlier posts on IPBiz [Sept. 4, Sept. 5] about patent litigation between Third Wave and Stratagene. Patents at Third Wave have been gained through the Bayh-Dole Act.